CFDB - Cystic Fibrosis DataBase

ongoing trials trial from other registries

Open-Label Phase 3 Trial to Evaluate the Safety of Aztreonam 75 mg Powder and Solvent for Nebuliser Solution/Aztreonam for Inhalation Solution (AZLI) in Children with Cystic Fibrosis (CF) and Chronic Pseudomonas aeruginosa (PA) in the Lower Airways

Study design (if review, criteria of inclusion for studies)

Completed. Study results posted -

Participants

Male, Female:; cystic fibrosis and chronic infection of lower respiratory tract with Pseudomonas aeruginosa:

Interventions

Aztreonam 75 mg Powder and Solvent for Nebuliser Solution/Aztreonam for Inhalation Solution (AZLI)

Keywords: Anti-Bacterial Agents; Aztreonam; Bacterial Infections; Colonization; Infection; Inhalation OR nebulised; pharmacological_intervention; Pseudomonas aeruginosa; Pseudomonas; Respiratory Tract Diseases; Respiratory Tract Infections; Monobactams; Powders;